Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Halpert

Showing results (101-110 of 205) with videos related to

Pageof 21
Sort By:
Biophysical Journal|April 19, 2005
Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probeDmitri R Davydov, Alexandra E Botchkareva, Nadezhda E Davydova, et al.
Molecular Pharmacology|February 21, 2002
Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivationKishore K Khan, You Qun He, Tammy L Domanski, et al.
Toxicology and Applied Pharmacology|April 1, 1994
Selective inhibitors of cytochromes P450J R Halpert, F P Guengerich, J R Bend, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4Kishore K Khan, You Qun He, Maria Almira Correia, et al.
Chemical Research in Toxicology|June 18, 2002
Site-directed mutagenesis of cytochrome P450eryF: implications for substrate oxidation, cooperativity, and topology of the active siteKishore K Khan, You Ai He, You Qun He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Characterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesisS L Born, G H John, G R Harlow, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroidsP A Klekotka, T H Richardson, E F Johnson, et al.
Protein Engineering, Design & Selection : PEDS|October 20, 2006
Engineering mammalian cytochrome P450 2B1 by directed evolution for enhanced catalytic tolerance to temperature and dimethyl sulfoxideSantosh Kumar, Ling Sun, Hong Liu, et al.
Biochemistry|January 3, 2007
Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probeTamara N Tsalkova, Nadezhda Y Davydova, James R Halpert, et al.
Physiological and Biochemical Zoology : PBZ|September 3, 2013
An in vivo assay for elucidating the importance of cytochromes P450 for the ability of a wild mammalian herbivore (Neotoma lepida) to consume toxic plantsMichele M Skopec, Jael R Malenke, James R Halpert, et al.
Pageof 21

Showing results (101-110 of 205) with videos related to

Sort By:
Pageof 21
Biophysical Journal|April 19, 2005
Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probeDmitri R Davydov, Alexandra E Botchkareva, Nadezhda E Davydova, et al.
Molecular Pharmacology|February 21, 2002
Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivationKishore K Khan, You Qun He, Tammy L Domanski, et al.
Toxicology and Applied Pharmacology|April 1, 1994
Selective inhibitors of cytochromes P450J R Halpert, F P Guengerich, J R Bend, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4Kishore K Khan, You Qun He, Maria Almira Correia, et al.
Chemical Research in Toxicology|June 18, 2002
Site-directed mutagenesis of cytochrome P450eryF: implications for substrate oxidation, cooperativity, and topology of the active siteKishore K Khan, You Ai He, You Qun He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
Characterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesisS L Born, G H John, G R Harlow, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroidsP A Klekotka, T H Richardson, E F Johnson, et al.
Protein Engineering, Design & Selection : PEDS|October 20, 2006
Engineering mammalian cytochrome P450 2B1 by directed evolution for enhanced catalytic tolerance to temperature and dimethyl sulfoxideSantosh Kumar, Ling Sun, Hong Liu, et al.
Biochemistry|January 3, 2007
Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probeTamara N Tsalkova, Nadezhda Y Davydova, James R Halpert, et al.
Physiological and Biochemical Zoology : PBZ|September 3, 2013
An in vivo assay for elucidating the importance of cytochromes P450 for the ability of a wild mammalian herbivore (Neotoma lepida) to consume toxic plantsMichele M Skopec, Jael R Malenke, James R Halpert, et al.
Pageof 21